So why are albuterol inhalers rapidly disappearing from the market? Are CFC's really to blame or is the market transition to HFA inhalers with their higher cost and higher margins to blame. Call me cynical, but this seems to me to be another failing of the current health care system. It takes doing the right thing (eliminating CFC's) and turns it into a profit making - patient hurting debacle.
What am I missing here?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment